ClinicalTrials.gov
public full text
Public Domain
C-VISA BikDD: Liposome in Advanced Pancreatic Cancer
The goal of this clinical research study is to find the highest tolerable dose of BikDD nanoparticle that can be given to patients with advanced cancer of the pancreas. The safety of this drug will also be studied.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage#883032
- Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)#891657
- Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma#1033278
- Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer#1009115
- Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer#311139
Record · ID 854051
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive